0.6901
price down icon2.11%   -0.0148
after-market アフターアワーズ: .71 0.0199 +2.89%
loading
前日終値:
$0.7049
開ける:
$0.6829
24時間の取引高:
24,123
Relative Volume:
0.69
時価総額:
$28.07M
収益:
-
当期純損益:
$-24.77M
株価収益率:
-0.8962
EPS:
-0.77
ネットキャッシュフロー:
$-17.36M
1週間 パフォーマンス:
-7.99%
1か月 パフォーマンス:
-0.14%
6か月 パフォーマンス:
-30.30%
1年 パフォーマンス:
-33.65%
1日の値動き範囲:
Value
$0.67
$0.71
1週間の範囲:
Value
$0.6661
$0.7998
52週間の値動き範囲:
Value
$0.57
$1.90

Mink Therapeutics Inc Stock (INKT) Company Profile

Name
名前
Mink Therapeutics Inc
Name
セクター
Healthcare (1196)
Name
電話
212-994-8250
Name
住所
149 FIFTH AVENUE, NEW YORK
Name
職員
37
Name
Twitter
Name
次回の収益日
2024-08-13
Name
最新のSEC提出書
Name
INKT's Discussions on Twitter

INKT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
INKT 0.6901 28.07M 0 -24.77M -17.36M -0.77
VRTX 450.37 115.43B 10.63B -479.80M -1.35B 13.33
REGN 744.50 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 596.74 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 246.80 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 108.23 24.89B 3.30B -501.07M 1.03B 11.54

Mink Therapeutics Inc (INKT) 最新ニュース

pulisher
Nov 19, 2024

MiNK Therapeutics (NASDAQ:INKT) Given New $4.00 Price Target at Robert W. Baird - Defense World

Nov 19, 2024
pulisher
Nov 17, 2024

Bright Mountain Media, Inc. Enters into Executive Employment Agreement with CEO Matthew DrinkwaterOn November 8, 2024, Bright Mountain Media, Inc. (OTCMKTS:BMTM) announced in an 8-K filing that they had entered into an Executive Employment Agr - Defense World

Nov 17, 2024
pulisher
Nov 15, 2024

MiNK Therapeutics, Inc. (NASDAQ:INKT) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024
pulisher
Nov 15, 2024

MiNK Therapeutics stock target cut, rating held amid pipeline updates By Investing.com - Investing.com UK

Nov 15, 2024
pulisher
Nov 15, 2024

MiNK Therapeutics Inc (INKT) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... By GuruFocus - Investing.com Canada

Nov 15, 2024
pulisher
Nov 14, 2024

MiNK Therapeutics Reports Q3 Growth and Strategic Advances - TipRanks

Nov 14, 2024
pulisher
Nov 14, 2024

Earnings call: MiNK Therapeutics succeeded in reducing costs by 60% - Investing.com

Nov 14, 2024
pulisher
Nov 14, 2024

MiNK Therapeutics Inc (INKT) Quarterly 10-Q Report - Quartzy

Nov 14, 2024
pulisher
Nov 14, 2024

Agenus (AGEN) Stock Dips Amid Financial Performance and Industry Trends - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

MiNK Therapeutics Reports Third Quarter 2024 Results and Business Update - GlobeNewswire

Nov 14, 2024
pulisher
Nov 12, 2024

MiNK Therapeutics to Provide Corporate Update and Third Quarter 2024 Financial Report - GlobeNewswire

Nov 12, 2024
pulisher
Nov 11, 2024

NK Cell Therapy Clinical Trial Pipeline Appears Robust With 140+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Malaysian Reserve

Nov 11, 2024
pulisher
Nov 11, 2024

MiNK Therapeutics Sets Q3 2024 Earnings Call: iNKT Cell Therapy Updates Ahead | INKT Stock News - StockTitan

Nov 11, 2024
pulisher
Nov 11, 2024

Hedge funds pile into banks, dump green energy post US election, Goldman Sachs says - Yahoo Canada Finance

Nov 11, 2024
pulisher
Nov 07, 2024

MiNK’s iNKT Cell Therapy Shows Potential for Optimal Multi-Combination for Resistant Solid Cancers at SITC 2024 - GlobeNewswire

Nov 07, 2024
pulisher
Nov 07, 2024

MiNK’s iNKT Cell Therapy Shows Potential for Optimal Multi-Combination for Resistant Solid - The Bakersfield Californian

Nov 07, 2024
pulisher
Nov 05, 2024

AGENAgenus Inc. Latest Stock News & Market Updates - StockTitan

Nov 05, 2024
pulisher
Nov 05, 2024

Agenus to Provide Third Quarter 2024 Financial Report and Corporate Update - Business Wire

Nov 05, 2024
pulisher
Oct 31, 2024

MiNK Therapeutics Appoints Dr. Robert Kadlec to Board - TipRanks

Oct 31, 2024
pulisher
Oct 31, 2024

Dogwood Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Thursday, November 7, 2024 - The Manila Times

Oct 31, 2024
pulisher
Oct 31, 2024

MiNK Therapeutics Announces Appointment of Dr. Robert Kadlec to Board of Directors - GlobeNewswire

Oct 31, 2024
pulisher
Oct 30, 2024

Small Cell Lung Cancer Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - The Globe and Mail

Oct 30, 2024
pulisher
Oct 30, 2024

Amazon.com Inc (AMZN-Q) QuotePress Release - The Globe and Mail

Oct 30, 2024
pulisher
Oct 28, 2024

Tesla Inc (TSLA-Q) QuotePress Release - The Globe and Mail

Oct 28, 2024
pulisher
Oct 28, 2024

TSX Utilities Capped Index (TTUT) QuotePress Release - The Globe and Mail

Oct 28, 2024
pulisher
Oct 28, 2024

BBerg Commodity Index (AHH20) Quote - The Globe and Mail

Oct 28, 2024
pulisher
Oct 28, 2024

TSX Industrials Capped Index (TTIN) QuotePress Release - The Globe and Mail

Oct 28, 2024
pulisher
Oct 28, 2024

Altria Group (MO-N) QuotePress Release - The Globe and Mail

Oct 28, 2024
pulisher
Oct 28, 2024

TSX 60 Equal Weight Index (TXEW) QuotePress Release - The Globe and Mail

Oct 28, 2024
pulisher
Oct 28, 2024

TSX Energy Capped Index (TTEN) QuotePress Release - The Globe and Mail

Oct 28, 2024
pulisher
Oct 28, 2024

Refractory Multiple Myeloma Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - The Globe and Mail

Oct 28, 2024
pulisher
Oct 28, 2024

Realty Income Corp (O-N) QuotePress Release - The Globe and Mail

Oct 28, 2024
pulisher
Oct 28, 2024

TSX Global Base Metals Index (TXBM) QuotePress Release - The Globe and Mail

Oct 28, 2024
pulisher
Oct 28, 2024

Nasdaq Biotechnology Index (NBI) QuotePress Release - The Globe and Mail

Oct 28, 2024
pulisher
Oct 28, 2024

Alphabet Cl C (GOOG-Q) QuotePress Release - The Globe and Mail

Oct 28, 2024
pulisher
Oct 28, 2024

Refractory Multiple Myeloma Pipeline Therapeutics, - openPR

Oct 28, 2024
pulisher
Oct 28, 2024

Vertiv Holdings Llc. (VRT-N) QuotePress Release - The Globe and Mail

Oct 28, 2024
pulisher
Oct 28, 2024

S&P 500 Information Technology [Sector] (SRIT) QuotePress Release - The Globe and Mail

Oct 28, 2024
pulisher
Oct 27, 2024

Meta Platforms Inc (META-Q) QuotePress Release - The Globe and Mail

Oct 27, 2024
pulisher
Oct 27, 2024

CAR-T Cell Therapy Competitive Landscape 2024 (Updated) - openPR

Oct 27, 2024
pulisher
Oct 19, 2024

MiNK Therapeutics announces executive transition By Investing.com - Investing.com Australia

Oct 19, 2024
pulisher
Oct 19, 2024

MiNK Therapeutics announces executive transition - Investing.com India

Oct 19, 2024
pulisher
Oct 14, 2024

Renaissance Technologies LLC Makes New Investment in Team, Inc. (NYSE:TISI) - Defense World

Oct 14, 2024
pulisher
Oct 11, 2024

Rx Rundown: AstraZeneca, Danco Laboratories, GSK and more - MM+M Online

Oct 11, 2024
pulisher
Oct 10, 2024

Poseida Therapeutics’ Allogeneic CAR-T P-BCMA-ALLO1 Demonstrates 91% ORR in Enhanced Lymphodepletion Arm of R/R MM Study - CGTLive™

Oct 10, 2024
pulisher
Oct 09, 2024

MiNK Therapeutics Inc (INKT) Q2 2024 Earnings Call Highlights: Strategic Advances Amid ... By GuruFocus - Investing.com Canada

Oct 09, 2024
pulisher
Oct 09, 2024

Around the Helix: Cell and Gene Therapy Company Updates – October 9, 2024 - CGTLive™

Oct 09, 2024
pulisher
Oct 09, 2024

MiNK Therapeutics stock gets boost from new RNA collaboration with Autonomous - Investing.com Canada

Oct 09, 2024
pulisher
Oct 09, 2024

Mink Therapeutics and Autonomous Therapeutics target metastatic tumors through new collaboration - BioWorld Online

Oct 09, 2024
pulisher
Oct 09, 2024

Investor’s Toolkit: Key Ratios for Assessing MiNK Therapeutics Inc (INKT)’s Performance - The Dwinnex

Oct 09, 2024
pulisher
Oct 08, 2024

MiNK Therapeutics, Autonomous Therapeutics enter research collaboration - TipRanks

Oct 08, 2024

Mink Therapeutics Inc (INKT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.56%
$367.36
price up icon 0.77%
$194.56
price up icon 0.07%
$108.23
price up icon 5.98%
大文字化:     |  ボリューム (24 時間):